Status:
COMPLETED
Pharmacokinetics of Two Eletriptan Oral Formulations Given With and Without Water and the Commercial Tablet Formulation Given With Water
Lead Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Conditions:
Healthy Volunteers
Eligibility:
All Genders
21-55 years
Phase:
PHASE1
Brief Summary
The study will evaluate whether the blood concentrations of eletriptan administered using two test formulations of oral disintegrating tablets are comparable to those observed with the standard commer...
Eligibility Criteria
Inclusion
- Healthy subjects
- No CYP3A4 inhibitors
Exclusion
- Clinically significant disease in any organ system
- Positive urine drug screen
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00871806
Start Date
April 1 2009
End Date
April 1 2009
Last Update
January 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Singapore, Singapore, 188770